Commentary

Podcast

CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection

On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.

On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega. We discussed CMS's recent Medicare Part D and Medicare Advantage final rule and how it affects enrollees and health plans.

The final rule includes various measures, such as the requirements for health equity analysis and behavioral health provider inclusion. It also prioritizes access to accurate information for Medicare enrollees, mandates evidence-based supplemental benefits, and promotes biosimilar substitution.

Listen above or on one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify


Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Nicolas Ferreyros, managing director, Community Oncology Alliance
CK Wang, MD, COTA
Dr Xavier Leleu
Francesco Sparano, MSc
Lorna Warwick
Gordon Crofoot, MD, PA
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Hamlet Gasoyan, PhD
Coral Omene, MD, PhD, sitting for a vieo interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo